Algert Global LLC trimmed its stake in Lemonade, Inc. (NYSE:LMND – Free Report) by 18.2% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 67,783 shares of the company’s stock after selling 15,100 shares during the period. Algert Global LLC owned about 0.09% of Lemonade worth $1,118,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also made changes to their positions in the company. Marshall Wace LLP acquired a new position in shares of Lemonade in the second quarter valued at approximately $14,181,000. General Equity Holdings LP acquired a new position in shares of Lemonade in the second quarter valued at approximately $5,198,000. Millennium Management LLC grew its holdings in shares of Lemonade by 388.7% in the second quarter. Millennium Management LLC now owns 165,689 shares of the company’s stock valued at $2,734,000 after purchasing an additional 131,784 shares in the last quarter. Landscape Capital Management L.L.C. grew its holdings in shares of Lemonade by 17.6% in the third quarter. Landscape Capital Management L.L.C. now owns 321,882 shares of the company’s stock valued at $5,308,000 after purchasing an additional 48,260 shares in the last quarter. Finally, Caxton Associates LP acquired a new position in shares of Lemonade in the second quarter valued at approximately $737,000. 80.30% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In related news, CFO Timothy E. Bixby sold 2,050 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $18.24, for a total value of $37,392.00. Following the completion of the sale, the chief financial officer now owns 271,552 shares in the company, valued at $4,953,108.48. This represents a 0.75 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Adina Eckstein sold 23,644 shares of the company’s stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $40.00, for a total transaction of $945,760.00. Following the completion of the sale, the chief operating officer now owns 189,653 shares of the company’s stock, valued at approximately $7,586,120. This trade represents a 11.09 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 132,892 shares of company stock worth $5,283,045. Corporate insiders own 12.50% of the company’s stock.
Analyst Ratings Changes
Get Our Latest Report on Lemonade
Lemonade Stock Down 1.5 %
NYSE LMND opened at $49.16 on Friday. Lemonade, Inc. has a 52 week low of $14.03 and a 52 week high of $53.85. The stock has a market capitalization of $3.51 billion, a PE ratio of -16.17 and a beta of 1.68. The firm has a 50 day moving average of $25.50 and a two-hundred day moving average of $20.42.
Lemonade (NYSE:LMND – Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported ($0.95) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.02) by $0.07. Lemonade had a negative net margin of 43.51% and a negative return on equity of 32.85%. The business had revenue of $136.60 million during the quarter, compared to analysts’ expectations of $129.10 million. During the same quarter in the prior year, the business posted ($0.88) EPS. The company’s revenue for the quarter was up 19.3% on a year-over-year basis. On average, equities research analysts expect that Lemonade, Inc. will post -3.05 earnings per share for the current fiscal year.
About Lemonade
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Further Reading
- Five stocks we like better than Lemonade
- What is a Dividend King?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How to Choose Top Rated Stocks
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding LMND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lemonade, Inc. (NYSE:LMND – Free Report).
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.